Comvita funds trial looking at Mānuka and digestive health

Welcome to NZ Beekeepers+
Would you like to join the rest of our members? Feel free to sign up today.
Sign up
Comvita has formed a new scientific partnership with the University of Otago to understand how mānuka honey helps support digestive health | Content partnership

Comvita, New Zealand’s pioneering mānuka honey brand and global market leader have formed a new scientific partnership with the University of Otago’s departments of Medicine and Human Nutrition to understand how mānuka honey helps support digestive health.

The partnership will conduct groundbreaking research through a $1.3 million clinical trial to investigate the potential of mānuka honey to improve symptoms and quality of life in people suffering from gastrointestinal inflammation and pain related to digestive disorders.

Miller, a senior research fellow, says while there is scientific evidence that mānuka honey is an effective topical treatment for wounds and burns, the potential health benefits of consuming mānuka honey are less well understood. 

“Chinese consumers in particular use mānuka honey to soothe digestive symptoms, but how it really works is unknown. New bioactivity research conducted by Comvita with the Riddet Institute and Plant and Food Research points to lepteridine as playing a key role in the inhibition of enzymes involved in the development of gastrointestinal inflammation, ulceration and pain,” Miller says. 

Comvita lepteridine is a natural compound, trademarked by the company.

 


Top